Effect of 4‐Aminopyridine on Genioglossus Muscle Activity during Sleep in Healthy Adults

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Annals of the American Thoracic Society

• Publication date

  2017-06-30

• Fields of study

  Medicine

• Identifiers
  DOI 10.1513/AnnalsATS.201701-006OCPMID 28387543PMCID PMC5566293
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Desipramine Increases Genioglossus Activity and Reduces Upper Airway Collapsibility during Non-REM Sleep in Healthy Subjects.

  2016cited by this paper
• Neural Control of the Upper Airway: Respiratory and State-Dependent Mechanisms.

  2016cited by this paper
• Desipramine improves upper airway collapsibility and reduces OSA severity in patients with minimal muscle compensation

  2016cited by this paper
• Zopiclone Increases the Arousal Threshold without Impairing Genioglossus Activity in Obstructive Sleep Apnea.

  2016cited by this paper
• Enhanced upper-airway muscle responsiveness is a distinct feature of overweight/obese individuals without sleep apnea.

  2014cited by this paper
• Identification of a pharmacological target for genioglossus reactivation throughout sleep.

  2014cited by this paper
• Pharmacokinetics of Dalfampridine Extended Release 7.5-mg Tablets in Healthy Subjects and Individuals With Mild and Moderate Renal Impairment: An Open-Label Study

  2013cited by this paper
• K+ channel modulation causes genioglossus inhibition in REM sleep and is a strategy for reactivation.

  2013cited by this paper
• Sensitization of upper airway mechanoreceptors as a new pharmacologic principle to treat obstructive sleep apnea: investigations with AVE0118 in anesthetized pigs.

  2013cited by this paper
• Identification of the mechanism mediating genioglossus muscle suppression in REM sleep.

  2013cited by this paper
• Defining phenotypic causes of obstructive sleep apnea. Identification of novel therapeutic targets.

  2013cited by this paper
• Obstructive sleep apnea.

  2012cited by this paper
• The safety profile of dalfampridine extended release in multiple sclerosis clinical trials.

  2012cited by this paper
• Rules for Scoring Respiratory Events in Sleep: Update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events

  2012cited by this paper
• The effect of increased genioglossus activity and end-expiratory lung volume on pharyngeal collapse.

  2010cited by this paper
• Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial.

  2009cited by this paper
• Airway dilator muscle activity and lung volume during stable breathing in obstructive sleep apnea.

  2009cited by this paper
• Endogenous excitatory drive modulating respiratory muscle activity across sleep-wake states.

  2006cited by this paper
• Genioglossus muscle responsiveness to chemical and mechanical stimuli during non-rapid eye movement sleep.

  2002cited by this paper
• TASK-1, a two-pore domain K+ channel, is modulated by multiple neurotransmitters in motoneurons.

  2000cited by this paper
• Changes in pharyngeal respiratory muscle force produced by K+ channel blockade.

  1995cited by this paper
• Use of 4-Aminopyridine to Reverse Morphine-Induced Respiratory Depression in Man

  1982cited by this paper
• The effects of 4‐aminopyridine and tetraethylammonium ions on normal and demyelinated mammalian nerve fibres.

  1981cited by this paper
• 4-Aminopyridine reversal of fentanyl-induced respiratory depression in normocapnic and hypercapnic patients.

  1981cited by this paper
• Use of 4-aminopyridine to reverse morphine-induced respiratory depression in man.

  1981cited by this paper

• Pharmacological interventions for the treatment of obstructive sleep apnea syndrome

  2024cites this paper
• Summary of drug therapy to treat cognitive impairment-induced obstructive sleep apnea

  2023cites this paper
• Pharmacotherapy for obstructive sleep apnea: targeting specific pathophysiological traits

  2023cites this paper
• Targets for obstructive sleep apnea pharmacotherapy: principles, approaches, and emerging strategies

  2023cites this paper
• Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome

  2023cites this paper
• Task Accomplished: Promising Effects of a New Topical Potassium Channel Antagonist in OSA.

  2023cites this paper
• Effectiveness and safety profile of cladribine in an Italian real-life cohort of relapsing–remitting multiple sclerosis patients: a monocentric longitudinal observational study

  2023cites this paper
• Effects of atomoxetine plus a hypnotic on obstructive sleep apnea severity in patients with a moderately collapsible pharyngeal airway

  2023cites this paper
• Turning Over a New Leaf-Pharmacologic Therapy in Obstructive Sleep Apnea.

  2022cites this paper
• Overview of the Role of Pharmacological Management of Obstructive Sleep Apnea

  2022cites this paper
• Topical K+ channel blockage improves pharyngeal collapsibility: A translational, placebo-controlled trial.

  2022cites this paper
• Application of personalized medicine to obstructive sleep apnea in China.

  2021cites this paper
• Impact of cold and flu medication on obstructive sleep apnoea and its underlying traits: A pilot randomized controlled trial

  2021cites this paper
• The pharmacotherapeutic management of obstructive sleep apnea

  2019cites this paper
• Targeting Endotypic Traits with Medications for the Pharmacological Treatment of Obstructive Sleep Apnea. A Review of the Current Literature

  2019cites this paper
• The Combination of Atomoxetine and Oxybutynin Greatly Reduces Obstructive Sleep Apnea Severity. A Randomized, Placebo-controlled, Double-Blind Crossover Trial.

  2019cites this paper
• Reply to Patel and Althouse: Robust Methods Are Needed to Evaluate the Pharmacologic Treatment of Obstructive Sleep Apnea

  2019cites this paper
• Phenotypic approach to pharmacotherapy in the management of obstructive sleep apnoea.

  2019cites this paper
• Drug Therapy in Obstructive Sleep Apnea.

  2018cites this paper
• Sleeping tongue: current perspectives of genioglossus control in healthy individuals and patients with obstructive sleep apnea

  2018cites this paper
• Obstructive sleep apnea: current perspectives

  2018cites this paper
• Personalized Management Approach for OSA

  2017cites this paper
• Personalized Management Approach for Obstructive Sleep Apnea

  2017cites this paper